Skip to main content

Press Release

Primary End-Point achieved in Phase IIb Study (FLUTE™) for APT-1011

For Patients With Eosinophilic Esophagitis

Press Releases

Stay up-to-date with the latest press information for Adare Pharmaceuticals.

April 15, 2019

Adare acquires Egalet’s proprietary “Parvulet™” technology platform

Read Press Release
March 12, 2019

Primary End-Point achieved in Phase IIb Study (FLUTE™) for APT-1011

Read Press Release
October 22, 2018

Lannett and Adare Enter Into Distribution Agreement

Read Press Release
October 8, 2018

Adare Licenses Cyclobenzaprine Hydrochloride in Portugal

Read Press Release
May 8, 2018

Adare Pharmaceuticals announces changes to Executive Leadership Team

Read Press Release
July 7, 2017

John Fraher, CEO of Adare Pharmaceuticals Named EY Entrepreneur of the Year® 2017 Award Winner in New Jersey

Read Press Release
September 28, 2016

Adare Pharmaceuticals Celebrates Corporate Headquarters Grand Opening

Read Press Release
June 6, 2016

Adare Pharmaceuticals Company Spotlight Presentation at BIO International 2016 Convention

Read Press Release
November 17, 2015

Adare Pharmaceuticals Partners with Cincinnati Children’s on Innovation Fund

Read Press Release
October 15, 2015

Adare Pharmaceuticals Appoints James Jogerst as Vice President, Corporate Development

Read Press Release
August 26, 2015

Adare Pharmaceuticals Appoints Joseph Del Buono as Vice President, Finance and Chief Financial Officer

Read Press Release
April 1, 2015

TPG Completes Acquisition of Aptalis Pharmaceutical Technologies summary: Company Renamed Adare Pharmaceuticals

Read Press Release

2019 Conferences

Want to meet us? Visit us at the following conferences around the world or set up an appointment by contacting us.

Looking to partner with us?

This site is protected by reCAPTCHA. The Google Privacy Policy and Terms of Use apply.